Predicting Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer

IMPORTANCE: Accurate, accessible predictions of posttreatment hearing loss for patients with head and neck cancer prior to the initiation of treatment are a necessary part of informed patient decision-making. OBJECTIVE: To develop a prediction model for postradiotherapy and/or post–cisplatin chemoth...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Otolaryngol Head Neck Surg
Autors principals: Schuette, Andrew, Lander, Daniel P., Kallogjeri, Dorina, Collopy, Cathryn, Goddu, Sneha, Wildes, Tanya M., Daly, Mackenzie, Piccirillo, Jay F.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2020
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6902235/
https://ncbi.nlm.nih.gov/pubmed/31750863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoto.2019.3550
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars